hims & hers fda warning letter compounded semaglutide 2025 cancels plans to sell GLP-1 pill after backlash Hims & Hers' Super Bowl

For brand-name meds approved for weight loss, this means having a BMI of 30 or higher, or 27+ with a weight-related condition such as high blood pressure

The medication is produced by licensed 503A compounding pharmacies and is available in all 50 states without insurance or membership fees

Ongoing Phase 3 Trials Several phase 3 trials are underway investigating the efficacy of retatrutide in larger populations (Fig

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context by identifying predispositions in key pathwaysincluding GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 variantsthat relate to how your body responds to GLP-1 agonists